Emerald Mutual Fund Advisers Trust’s Oric Pharmaceuticals ORIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-742,666
Closed -$15.5M – 228
2021
Q3
$15.5M Buy
742,666
+185,456
+33% +$3.76M 0.54% 67
2021
Q2
$9.9M Sell
557,210
-67,000
-11% -$1.47M 0.32% 106
2021
Q1
$15.3M Buy
624,210
+135,976
+28% +$4.3M 0.51% 85
2020
Q4
$16.5M Buy
488,234
+175,751
+56% +$5.04M 0.58% 74
2020
Q3
$7.82M Buy
312,483
+143,315
+85% +$3.41M 0.35% 87
2020
Q2
$5.71M Buy
+169,168
New +$5.4M 0.27% 107

Other funds holding ORIC

Emerald Mutual Fund Advisers Trust's ORIC Position: Q4 2021 in Review

Emerald Mutual Fund Advisers Trust sold out of Oric Pharmaceuticals (ORIC) in Q4 2021, closing a stake of 742,666 shares — an estimated $15.5M sold.

Emerald Mutual Fund Advisers Trust first reported a position in ORIC in Q2 2020 and held it in 6 quarters. The position peaked at $16.5M in Q4 2020. 80 funds tracked by Wall St. Rank hold ORIC as of Q4 2021.

  • Emerald Mutual Fund Advisers Trust reported no remaining Oric Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 742,666 Oric Pharmaceuticals shares in Q4 2021, an estimated $15.5M.
  • Emerald Mutual Fund Advisers Trust first reported a position in Oric Pharmaceuticals in Q2 2020 and held it in 6 quarters.
  • Emerald Mutual Fund Advisers Trust's Oric Pharmaceuticals position peaked at $16.5M in Q4 2020.
  • 80 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q4 2021.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2021, filed 2 Feb 2022.